Altshuler Shaham LTD Vertex Pharmaceuticals Inc Transaction History

Altshuler Shaham LTD

$1.57 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $257,290 - $318,022	-655 Reduced 17.92%	3,000 $1.41 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $345,313 - $377,829	-847 Reduced 18.81%	3,655 $1.53 Million
Q4 2023 Feb 07, 2024	BUY	$343.0 - $410.68 $1.52 Million - $1.82 Million	4,435 Added 6619.4%	4,502 $1.83 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $6,425 - $6,886	-19 Reduced 22.09%	67 $23,000
Q2 2023 Jul 24, 2023	BUY	$314.42 - $351.91 $27,040 - $30,264	86 New	86 $30,000
Q1 2023 May 09, 2023	SELL	$283.23 - $323.1 $145,296 - $165,750	-513 Closed	0 $0
Q4 2022 May 09, 2023	SELL	$285.76 - $321.48 $52,579 - $59,152	-184 Reduced 26.4%	513 $148,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $32,585 - $36,358	-119 Reduced 14.58%	697 $204,000
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $52,866 - $65,823	-225 Reduced 21.61%	816 $230,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $230,498 - $271,669	1,041 New	1,041 $272,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $25,394 - $28,418	-140 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $26,248 - $30,954	140 New	140 $28,000
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $91,705 - $122,307	-443 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$255.65 - $303.1 $319,051 - $378,268	-1,248 Reduced 73.8%	443 $121,000
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $113,867 - $149,379	-505 Reduced 23.0%	1,691 $491,000
Q1 2020 May 12, 2020	BUY	$199.77 - $247.81 $410,327 - $509,001	2,054 Added 1446.48%	2,196 $523,000
Q4 2019 Feb 11, 2020	BUY	$166.71 - $223.91 $13,670 - $18,360	82 Added 136.67%	142 $31,000
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $9,973 - $11,225	60 New	60 $10,000
Q2 2019 Aug 06, 2019	SELL	$164.61 - $190.37 $7,242 - $8,376	-44 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $163 - $194	-1 Reduced 2.22%	44 $8,000
Q4 2018 Feb 11, 2019	BUY	$151.91 - $192.21 $6,835 - $8,649	45 New	45 $7,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.

Account